IBM

Amazon, Google, IBM, Microsoft, Oracle and Salesforce representatives speaking at the White House in Washington, D.C.
By Tom Sullivan August 13, 2018
WASHINGTON, DC – A broad coalition of technology giants took the stage in an unscheduled session at the Blue Button 2.0 Developer Conference here in the White House.  Specifically, Amazon, Google, IBM, Microsoft, Oracle and Salesforce came together to pledge to remove interoperability barriers.  Dean Garfield, CEO of the Information Technology Industry Council, lead the session and described the...
By Laura Lovett July 26, 2018
WebMD goes to China. WebMD is teaming up with Chinese tech giant Tencent in a deal that would introduce the health information platform to Asia. This means that WebMD’s services will be translated into Chinese and localized to suit the Chinese population.  “The agreement between WebMD and Tencent has the power to make a difference in the health of the Chinese people,” said Meng Zhang, general...
By Dave Muoio July 19, 2018
The Department of Veterans Affairs and IBM Watson Health have announced a one-year extension to an ongoing public-private partnership applying the AI company’s technology to genomic data for cancer therapy. The precision oncology collaboration has so far assisted the treatment of more than 2,700 veterans, according to a statement, although the original agreement in 2016 had proposed the lofty...
By Jonah Comstock March 1, 2018
It’s hard to be a printer and typewriter company in 2018. But IBM spinoff Lexmark has found that many areas — including healthcare — still have a need for its services. “As much as we want to go paperless, there are organizations and processes that unfortunately are still rooted in paper,” Marty DeGraff, Lexmark’s industry director for government, education, and healthcare. “Which is good for us...
By Dave Muoio December 5, 2017
Last week, hundreds of digital health entrepreneurs, investors, and executives met in Boston for the annual Digital Healthcare Innovation Summit. Among the more frequently discussed trends and technologies was artificial intelligence — its promise, its stumbles, and how it should be implemented to best serve healthcare. “I started marketing Watson for Oncology in January of 2016. I’m almost...
By Bernie Monegain September 8, 2017
Big Blue is investing $240 million over 10 years to build the MIT-IBM Watson AI Lab in partnership with MIT. The lab will engage in research into artificial intelligence with the goal of driving scientific AI breakthroughs. The collaboration will focus on AI hardware, software, and algorithms related to deep learning and other areas. It aims to increase AI’s impact on industries, such as...
By Jeff Lagasse August 21, 2017
IBM and JDRF, a global organization funding Type 1 diabetes research, are joining forces. The collaboration will develop machine learning methods and use them to analyze years of Type 1 research data to pinpoint the factors that can contribute to the onset of the condition in children.   Type 1 diabetes  -- T1D for short -- affects about 1.25 million Americans, and to date does not have a cure....
By Heather Mack June 2, 2017
It’s been six years since IBM first alluded to plans to build artificially intelligent physician’s assistant. Even as that mission became more concrete with a formal launch of the health-focused Watson and years of near-constant announcements and partnerships, it still hasn’t been clear just exactly what impact the cognitive computing program will have on healthcare. But newly shared data could...
By Heather Mack May 25, 2017
Temporary doctor staffing platform wanders west. Nomad Health, which offers an online platform to connect doctors with freelance clinical work, has expanded its footprint into California and Texas. Founded in 2015 (and serving all of the east coast), the company works to offset doctor staffing shortages using a cloud-based virtual marketplace rather than the often time-consuming paper, phone and...
By Heather Mack April 24, 2017
Out of the 422 million people around the world living with diabetes, one in three of them will develop diabetic retinopathy (DR), a common condition that can lead to permanent blindness if left untreated. While early detection and treatment can dramatically reduce that risk, a third of people with diabetes have never even been screened for DR, as many are living in low-income, medically...